Ménière’s disease
P. H. Van de Heyning *, C. F. J. De Valck *, A. Boudewyns *, T. Cammaert **, S. Casteleyn ***, N. Deggouj ***, F. Gordts****, G. Forton* *****, Ph. Lefebvre****** and Th. Robillard*******
*University of Antwerp, Antwerp University Hospital, Antwerp; **Department of Otorhinolaryngology, St Lucas General Hospital, Ghent; ***Department of Otorhinolaryngology, University Hospital St Luc UCL, Brussels; ****Department of Otorhinolaryngology, University Hospital Free University, Brussels; *****Department of Otorhinolaryngology, Heilig Hart General Hospital, Roeselare; ******Department of Otorhinolaryngology, Sart Tilman University Hospital University, Liège; *******Department of Otorhinolaryngology, Clinique Sainte-Elisabeth, Namur
Guidelines; Ménière’s disease; inner ear; treatment
11 - 20
Ménière’s disease. Ménière’s disease is an idiopathic inner ear disorder characterized by endolymphatic hydrops (ELH), vertigo attacks, sensorineural hearing loss, tinnitus and pressure sensation in the affected ear. The disorder has to be differentiated from known causes of ELH and from other disorders provoking similar symptoms. Ménière’s disease can seriously affect quality of life, and medical support is often necessary on a life long basis. The treatment modalities are counselling, preventive measures and life style adaptation, drug therapy, tinnitus coping, provision of hearing devices, and sometimes surgery. We review the indications for these modalities, and the evidence level of their beneficial effect.
Suppl. 6, 2007

Ménière’s disease